Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XHR
2801
Xenia Hotels & Resorts
XHR
$1.82B
| $627K | ﹤0.01% |
43,734
-55,115
| -56% | -$798K |
|
|
LBPH
2802
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $625K | ﹤0.01% |
23,137
-6,457
| -22% | -$127K |
|
|
NTST
2803
NETSTREIT Corp
NTST
$2.14B
| $625K | ﹤0.01% |
38,840
-36,885
| -49% | -$634K |
|
2804
Extreme Networks
EXTR
$3.19B
| $624K | ﹤0.01% |
46,375
-72,043
| -61% | -$828K |
|
2805
Methode Electronics
MEI
$585M
| $624K | ﹤0.01% |
60,261
-13,382
| -18% | -$154K |
|
|
HAPN
2806
Happen Inc
HAPN
$2.27B
| $623K | ﹤0.01% |
73,678
-57,883
| -44% | -$495K |
|
|
TEF
2807
DELISTED
Telefonica
TEF
| $621K | ﹤0.01% |
147,533
+53,922
| +58% | +$238K |
|
2808
Alignment Healthcare
ALHC
$2.78B
| $620K | ﹤0.01% |
79,255
-59,766
| -43% | -$390K |
|
2809
Magnite
MGNI
$3.49B
| $618K | ﹤0.01% |
46,505
-73,198
| -61% | -$800K |
|
|
ITCI
2810
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $618K | ﹤0.01% |
9,018
-83,403
| -90% | -$5.78M |
|
|
LAND
2811
Gladstone Land Corp
LAND
$360M
| $614K | ﹤0.01% |
44,838
-17,880
| -29% | -$235K |
|
2812
Skyward Specialty Insurance
SKWD
$2.66B
| $613K | ﹤0.01% |
16,951
-9,386
| -36% | -$340K |
|
2813
Assured Guaranty
AGO
$3.66B
| $611K | ﹤0.01% |
7,923
-31,653
| -80% | -$2.47M |
|
2814
Liberty Latin America Class C
LILAK
$1.68B
| $611K | ﹤0.01% |
69,867
-83,770
| -55% | -$625K |
|
2815
United States Lime & Minerals
USLM
$3.34B
| $611K | ﹤0.01% |
8,385
-6,200
| -43% | -$413K |
|
2816
Vishay Precision Group
VPG
$906M
| $610K | ﹤0.01% |
20,046
+5,145
| +35% | +$169K |
|
2817
Payoneer
PAYO
$2.41B
| $610K | ﹤0.01% |
110,143
-148,082
| -57% | -$801K |
|
|
JOYY
2818
JOYY Inc
JOYY
$3.77B
| $610K | ﹤0.01% |
20,273
-1,727
| -8% | -$55.1K |
|
|
NOVA
2819
DELISTED
Sunnova Energy
NOVA
| $609K | ﹤0.01% |
109,220
-1,588,963
| -94% | -$7.55M |
|
2820
Sprinklr
CXM
$1.55B
| $609K | ﹤0.01% |
63,329
-47,397
| -43% | -$530K |
|
2821
LeMaitre Vascular
LMAT
$1.85B
| $609K | ﹤0.01% |
7,397
-10,551
| -59% | -$775K |
|
2822
Tango Therapeutics
TNGX
$4.72B
| $608K | ﹤0.01% |
70,811
-112,675
| -61% | -$871K |
|
2823
FIGS
FIGS
$1.88B
| $606K | ﹤0.01% |
113,658
-496,828
| -81% | -$2.54M |
|
2824
Global Net Lease
GNL
$1.91B
| $606K | ﹤0.01% |
82,391
-102,570
| -55% | -$744K |
|
2825
V2X
VVX
$2.65B
| $605K | ﹤0.01% |
12,617
-6,456
| -34% | -$306K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.